[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITME20040015A1 - Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. - Google Patents

Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.

Info

Publication number
ITME20040015A1
ITME20040015A1 IT000015A ITME20040015A ITME20040015A1 IT ME20040015 A1 ITME20040015 A1 IT ME20040015A1 IT 000015 A IT000015 A IT 000015A IT ME20040015 A ITME20040015 A IT ME20040015A IT ME20040015 A1 ITME20040015 A1 IT ME20040015A1
Authority
IT
Italy
Prior art keywords
phosphorus
tablets
phosphate
slow
chelanti
Prior art date
Application number
IT000015A
Other languages
English (en)
Inventor
Vincenzo Savica
Original Assignee
Vincenzo Savica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36035790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITME20040015(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vincenzo Savica filed Critical Vincenzo Savica
Priority to IT000015A priority Critical patent/ITME20040015A1/it
Publication of ITME20040015A1 publication Critical patent/ITME20040015A1/it
Priority to RSP-2010/0513A priority patent/RS51507B/en
Priority to JP2007544881A priority patent/JP5049135B2/ja
Priority to AT05810997T priority patent/ATE481091T1/de
Priority to PL05810997T priority patent/PL1827386T3/pl
Priority to RU2007125702/15A priority patent/RU2392926C2/ru
Priority to ES05810997T priority patent/ES2352957T3/es
Priority to PCT/EP2005/056289 priority patent/WO2006061336A2/en
Priority to DK05810997.6T priority patent/DK1827386T3/da
Priority to SI200531182T priority patent/SI1827386T1/sl
Priority to CNA2005800414580A priority patent/CN101068535A/zh
Priority to KR1020077012746A priority patent/KR101283820B1/ko
Priority to CA2587924A priority patent/CA2587924C/en
Priority to EP05810997A priority patent/EP1827386B1/en
Priority to DE602005023648T priority patent/DE602005023648D1/de
Priority to MX2007006704A priority patent/MX2007006704A/es
Priority to PT05810997T priority patent/PT1827386E/pt
Priority to BRPI0518517-3A priority patent/BRPI0518517A2/pt
Priority to US11/792,047 priority patent/US7815898B2/en
Priority to US12/861,539 priority patent/US20100316578A1/en
Priority to US12/883,498 priority patent/US8518379B2/en
Priority to HR20100653T priority patent/HRP20100653T1/hr
Priority to CY20101101144T priority patent/CY1110985T1/el
Priority to US14/462,038 priority patent/US20140356297A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000015A 2004-12-07 2004-12-07 Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. ITME20040015A1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT000015A ITME20040015A1 (it) 2004-12-07 2004-12-07 Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
BRPI0518517-3A BRPI0518517A2 (pt) 2004-12-07 2005-11-29 composiÇÕes orais para absorÇço de compostos de fàsforo
US11/792,047 US7815898B2 (en) 2004-12-07 2005-11-29 Oral compositions for absorption of phosphorus compounds
SI200531182T SI1827386T1 (sl) 2004-12-07 2005-11-29 Oralni sestavki za absorpcijo fosforjevih spojin
CA2587924A CA2587924C (en) 2004-12-07 2005-11-29 Oral compositions for absorption of phosphorus compounds
AT05810997T ATE481091T1 (de) 2004-12-07 2005-11-29 Orale zusammensetzungen zur absorption von phosphorverbindungen
PL05810997T PL1827386T3 (pl) 2004-12-07 2005-11-29 Kompozycje doustne do absorpcji związków fosforu
RU2007125702/15A RU2392926C2 (ru) 2004-12-07 2005-11-29 Оральная композиция для абсорбции фосфорных соединений
ES05810997T ES2352957T3 (es) 2004-12-07 2005-11-29 Composiciones orales para la absorción de compuestos de fósforo.
PCT/EP2005/056289 WO2006061336A2 (en) 2004-12-07 2005-11-29 Oral compositions for absorption of phosphorus compounds
DK05810997.6T DK1827386T3 (da) 2004-12-07 2005-11-29 Orale sammensætninger til absorption af phosphor-forbindelser
RSP-2010/0513A RS51507B (en) 2004-12-07 2005-11-29 ORAL COMPOSITIONS FOR THE ABSORPTION OF PHOSPHORUS UNITS
CNA2005800414580A CN101068535A (zh) 2004-12-07 2005-11-29 用于吸收含磷化合物的口服组合物
KR1020077012746A KR101283820B1 (ko) 2004-12-07 2005-11-29 인 화합물의 흡수를 위한 경구용 조성물
JP2007544881A JP5049135B2 (ja) 2004-12-07 2005-11-29 リン化合物の吸収のための経口組成物
EP05810997A EP1827386B1 (en) 2004-12-07 2005-11-29 Oral compositions for absorption of phosphorus compounds
DE602005023648T DE602005023648D1 (de) 2004-12-07 2005-11-29 Orale zusammensetzungen zur absorption von phosphorverbindungen
MX2007006704A MX2007006704A (es) 2004-12-07 2005-11-29 Composiciones orales para la absorcion de compuestos de fosforo.
PT05810997T PT1827386E (pt) 2004-12-07 2005-11-29 Composições orais para a absorção de compostos de fósforo
US12/861,539 US20100316578A1 (en) 2004-12-07 2010-08-23 Oral compositions for absorption of phosphorous compounds
US12/883,498 US8518379B2 (en) 2004-12-07 2010-09-16 Oral compositions for absorption of phosphorous compounds
HR20100653T HRP20100653T1 (hr) 2004-12-07 2010-11-29 Oralne smjese za apsorpciju fosfornih spojeva
CY20101101144T CY1110985T1 (el) 2004-12-07 2010-12-10 Στοματικες συνθεσεις για απορροφηση των ενωσεων φωσφορου
US14/462,038 US20140356297A1 (en) 2004-12-07 2014-08-18 Oral compositions for absorption of phosphorous compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000015A ITME20040015A1 (it) 2004-12-07 2004-12-07 Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.

Publications (1)

Publication Number Publication Date
ITME20040015A1 true ITME20040015A1 (it) 2005-03-07

Family

ID=36035790

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000015A ITME20040015A1 (it) 2004-12-07 2004-12-07 Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.

Country Status (21)

Country Link
US (4) US7815898B2 (it)
EP (1) EP1827386B1 (it)
JP (1) JP5049135B2 (it)
KR (1) KR101283820B1 (it)
CN (1) CN101068535A (it)
AT (1) ATE481091T1 (it)
BR (1) BRPI0518517A2 (it)
CA (1) CA2587924C (it)
CY (1) CY1110985T1 (it)
DE (1) DE602005023648D1 (it)
DK (1) DK1827386T3 (it)
ES (1) ES2352957T3 (it)
HR (1) HRP20100653T1 (it)
IT (1) ITME20040015A1 (it)
MX (1) MX2007006704A (it)
PL (1) PL1827386T3 (it)
PT (1) PT1827386E (it)
RS (1) RS51507B (it)
RU (1) RU2392926C2 (it)
SI (1) SI1827386T1 (it)
WO (1) WO2006061336A2 (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
ITRM20060204A1 (it) * 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
AU2008354325A1 (en) * 2008-04-08 2009-10-15 Cypress Pharmaceutical, Inc. Phosphate-binding chitosan and uses thereof
US7943597B2 (en) * 2008-04-08 2011-05-17 Cypress Pharmaceutical, Inc. Phosphate-binding chitosan and uses thereof
US8877907B2 (en) 2010-06-07 2014-11-04 The Johns Hopkins University Molecularly imprinted polymers
US9314523B2 (en) 2010-09-21 2016-04-19 Elwha Llc Ingestible salt grabber
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
WO2012098562A2 (en) 2011-01-19 2012-07-26 Panacea Biotec Limited Liquid oral compositions of lanthanum salts
WO2012143011A1 (en) 2011-04-20 2012-10-26 Gumlink A/S Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
WO2012143008A1 (en) 2011-04-20 2012-10-26 Gumlink A/S Reduction of the level of free phosphorus compounds in the digestive juice
PL2717896T3 (pl) * 2011-06-08 2017-05-31 Kai Pharmaceuticals, Inc. Środki lecznicze do regulowania poziomu fosforu w surowicy krwi
EP3653061A1 (en) * 2012-09-04 2020-05-20 The Board of Regents of the University of Texas System Citrate-rich calcium-magnesium supplement and uses thereof
EP2983651B1 (en) 2013-04-12 2018-12-26 ExPharma Limited Compositions comprising a mixture of elastomers and chitosan and use thereof for treating disorders of phosphorous mineral metabolism
WO2014197725A1 (en) 2013-06-05 2014-12-11 Tricida, Inc. Proton-binding polymers for oral administration
EP2818176A1 (en) * 2013-06-27 2014-12-31 Virbac Composition for the treatment of progressive renal diseases
CN103536977A (zh) * 2013-11-04 2014-01-29 于杰 血液灌流器
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
PT3593808T (pt) 2014-12-10 2021-02-11 Tricida Inc Polímeros de ligação a protões para administração oral
MA44875A (fr) 2016-05-06 2019-03-13 Tricida Inc Compositions pour le traitement de troubles acido-basiques
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
AU2018360867A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
US20200383926A1 (en) * 2017-11-29 2020-12-10 Shin Era Technology Co. Ltd. Enteric coated pharmaceutical composition and use thereof
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
CN109528764B (zh) * 2018-09-30 2021-04-06 北京市中关村医院 一种凝胶基层状无机物磷结合剂及其制备方法和用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818807A (en) * 1972-12-06 1974-06-25 Eng Concrete Placer Inc Slurry pump piston seal
US4181718A (en) * 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4163777A (en) 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4163177A (en) * 1977-10-17 1979-07-31 Ward Derrick A Oscillation generator providing oscillations of varying amplitude
US4160820A (en) * 1977-11-28 1979-07-10 General Mills, Inc. Plaque inhibiting composition and method
US4386106A (en) * 1981-12-01 1983-05-31 Borden, Inc. Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition
US4515769A (en) * 1981-12-01 1985-05-07 Borden, Inc. Encapsulated flavorant material, method for its preparation, and food and other compositions incorporating same
US4512968A (en) * 1982-11-30 1985-04-23 Lion Corporation Oral compositions
JPS61161216A (ja) * 1985-01-11 1986-07-21 Teijin Ltd キトサン類を用いた徐放性医薬品組成物
EP0187703B1 (en) * 1985-01-11 1992-08-05 Teijin Limited Sustained release preparation
JPS62132830A (ja) 1985-12-05 1987-06-16 Teijin Ltd 徐放性医薬品組成物
JPS63310833A (ja) * 1987-06-10 1988-12-19 Nippon Medical Supply Corp リン吸着カプセル
DE3936319C3 (de) 1989-11-01 1997-05-07 Bartz Volker Phosphatbinder zur oralen Verabreichung
US5030459A (en) * 1989-11-07 1991-07-09 Warner-Lambert Company High impact mint flavor for high base chewing gum
JP2884124B2 (ja) * 1992-01-31 1999-04-19 鈴与株式会社 リン吸着剤
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
EP0793960B1 (en) 1996-03-05 2001-08-01 Mitsubishi Chemical Corporation Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia
IE980990A1 (en) * 1998-11-27 2000-05-31 Fuisz Internat Ltd Composition and Method for Medicated Chewing Gum Delivery System
DE19917705C1 (de) 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
FI121528B (fi) * 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
US20030072841A1 (en) * 2001-03-19 2003-04-17 The Procter & Gamble Campany Polybutene containing chewing gum and confection
ITMI20012320A1 (it) * 2001-11-06 2003-05-06 Perfetti Van Melle Spa Composizioni orali solide anti-tartaro e anti-placca batterica, utilicome coadiuvanti nell'igiene odonto-stomatologica
IL162823A0 (en) * 2002-01-03 2005-11-20 Yissum Res Dev Co Edible compositions capable of removing oral biofilm
US7244455B2 (en) 2002-01-16 2007-07-17 Warner-Lambert Company Center-filled chewing gum containing a deliverable form of calcium
SE0302947D0 (sv) * 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
PT1660104E (pt) 2003-08-26 2010-06-15 Shire Holdings Ag Formulação farmacêutica compreendendo compostos de lantânio
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
US8323683B2 (en) * 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula

Also Published As

Publication number Publication date
KR101283820B1 (ko) 2013-07-15
SI1827386T1 (sl) 2011-01-31
US20140356297A1 (en) 2014-12-04
ATE481091T1 (de) 2010-10-15
ES2352957T3 (es) 2011-02-24
RU2007125702A (ru) 2009-01-20
CA2587924A1 (en) 2006-06-15
PT1827386E (pt) 2010-12-03
US20100316578A1 (en) 2010-12-16
HRP20100653T1 (hr) 2011-01-31
CA2587924C (en) 2013-08-20
DE602005023648D1 (de) 2010-10-28
RU2392926C2 (ru) 2010-06-27
US20110002858A1 (en) 2011-01-06
WO2006061336A3 (en) 2006-09-14
US7815898B2 (en) 2010-10-19
US8518379B2 (en) 2013-08-27
MX2007006704A (es) 2008-01-16
RS51507B (en) 2011-06-30
CN101068535A (zh) 2007-11-07
KR20070090904A (ko) 2007-09-06
JP2008523022A (ja) 2008-07-03
EP1827386B1 (en) 2010-09-15
WO2006061336A2 (en) 2006-06-15
EP1827386A2 (en) 2007-09-05
CY1110985T1 (el) 2015-06-11
DK1827386T3 (da) 2011-07-11
PL1827386T3 (pl) 2011-05-31
US20080125394A1 (en) 2008-05-29
JP5049135B2 (ja) 2012-10-17
BRPI0518517A2 (pt) 2008-11-25

Similar Documents

Publication Publication Date Title
ITME20040015A1 (it) Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
UA108360C2 (uk) Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині
EA201490477A1 (ru) Фармацевтические составы, содержащие пропиленгликоль-гидрат дапаглифлозина
IL194277A (en) Zoladronic Acid Compounds for Oral Administration
WO2011079239A3 (en) Combination tablet with chewable outer layer
BRPI0516238A (pt) composição farmacêutica contendo diclofenaco
EA200702627A1 (ru) Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
NO20066076L (no) Tyggbar, sugbar og svelgbar tablett som inneholder en kalsium-inneholdende forbindelse som en aktiv substans
NO20043367L (no) Oralt farmasoytisk preparat
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
ZA200801575B (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
HUP0401200A2 (hu) Terbinafint tartalmazó gyógyszerészeti összetételek és eljárás előállításukra
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
WO2007131070A3 (en) Compositions, dosage forms and methods of treating emesis
WO2008060546A3 (en) Oral formulations
ATE457721T1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
BRPI0920842A2 (pt) goma de mascar contendo quantidades em baixa dose de vitaminas solúveis em água
EP1626697A4 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION WITH LITHIUM CARBONATE
ITMI20061741A1 (it) Composizioni farmaceutiche per la somministrazione orale di sostanze proteiche
EA201291118A1 (ru) Нутрицевтические и фармацевтические композиции, покрытые оболочкой из жевательной резинки
RU2004134082A (ru) Антигриппозное средство